We are live on ! Find out more
GS

Gagnon Securities Portfolio holdings

AUM $519M
1-Year Est. Return 44.91%
This Fund
S&P 500
This Quarter Est. Return
+18.46%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$504M
AUM Growth
+$60.4M
Cap. Flow
-$11.5M
Cap. Flow %
-2.29%
Top 10 Hldgs %
49.33%
Holding
108
New
11
Increased
40
Reduced
49
Closed
6

Top Buys

Rank Stock Value
1
TMCI icon
Treace Medical Concepts
TMCI
+$8.26M
2
ISRG icon
Intuitive Surgical
ISRG
+$5.31M
3
AMRC icon
Ameresco
AMRC
+$3.31M
4
FIVN icon
FIVE9
FIVN
+$2.81M
5
GNRC icon
Generac Holdings
GNRC
+$2.49M

Sector Composition

Rank Sector Weight
1 Healthcare 41.16%
2 Technology 18.14%
3 Industrials 16.52%
4 Consumer Discretionary 9.69%
5 Energy 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNA icon
1
CareDx
CDNA
$2.35B
$44.9M 8.9%
1,437,722
-736,445
-34% -$18.3M
ENSG icon
2
The Ensign Group
ENSG
$10.4B
$33.8M 6.7%
234,831
-363
-0.2% -$51.7K
AL
3
DELISTED
Air Lease Corp
AL
$33.2M 6.59%
733,644
-3,850
-0.5% -$176K
ISRG icon
4
Intuitive Surgical
ISRG
$133B
$30.5M 6.05%
62,070
+11,399
+22% +$5.31M
WGS icon
5
GeneDx Holdings
WGS
$2.08B
$23M 4.56%
541,943
-31,096
-5% -$1.05M
PSIX
6
Power Solutions International
PSIX
$759M
$21M 4.15%
1,019,627
-263,026
-21% -$5.41M
AMRC icon
7
Ameresco
AMRC
$1.36B
$17.7M 3.51%
466,341
+107,068
+30% +$3.31M
EXAS
8
DELISTED
Exact Sciences
EXAS
$15.9M 3.15%
233,583
-12,920
-5% -$729K
EPD icon
9
Enterprise Products Partners
EPD
$81.6B
$14.6M 2.89%
501,262
+4,866
+1% +$142K
BLFS icon
10
BioLife Solutions
BLFS
$1.65B
$14.3M 2.83%
569,378
-7,855
-1% -$186K
SCWX
11
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$13.2M 2.62%
1,493,859
-635
-0% -$4.79K
NVGS icon
12
Navigator Holdings
NVGS
$1.27B
$12.8M 2.53%
794,642
-16,328
-2% -$267K
CARG icon
13
CarGurus
CARG
$3.28B
$12.5M 2.47%
415,262
-4,385
-1% -$118K
KMX icon
14
CarMax
KMX
$8.04B
$12.3M 2.44%
158,826
+320
+0.2% +$25.3K
PROF
15
Profound Medical
PROF
$290M
$11.7M 2.32%
1,467,247
-41,274
-3% -$373K
EQIX icon
16
Equinix
EQIX
$104B
$11.4M 2.27%
12,871
-453
-3% -$371K
FRSH icon
17
Freshworks
FRSH
$3.18B
$10.6M 2.09%
920,245
+184,614
+25% +$2.21M
TMCI icon
18
Treace Medical Concepts
TMCI
$310M
$10.3M 2.04%
1,770,163
+1,286,582
+266% +$8.26M
BL icon
19
BlackLine
BL
$1.79B
$10.2M 2.02%
184,986
-601
-0.3% -$29.6K
FIVN icon
20
FIVE9
FIVN
$2.27B
$9.52M 1.89%
331,499
+77,967
+31% +$2.81M
ZUO
21
DELISTED
Zuora, Inc.
ZUO
$9.05M 1.79%
1,050,133
+19,907
+2% +$177K
CAKE icon
22
Cheesecake Factory
CAKE
$5.23B
$8.87M 1.76%
218,801
+376
+0.2% +$14.3K
GNRC icon
23
Generac Holdings
GNRC
$12.8B
$8.7M 1.72%
54,756
+16,816
+44% +$2.49M
CMG icon
24
Chipotle Mexican Grill
CMG
$43.7B
$8.57M 1.7%
148,742
-2,294
-2% -$127K
AOSL icon
25
Alpha and Omega Semiconductor
AOSL
$974M
$7.98M 1.58%
214,951
-96,872
-31% -$3.68M

Similar funds

Gagnon Securities's Q3 2024 Portfolio in Review

As of Q3 2024, Gagnon Securities held 108 positions worth $504M, up 14% from $444M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Gagnon Securities's Q3 2024 filing shows 11 new, 40 increased, 49 reduced and 6 closed positions. Its largest new stake was Intel: 21,514 shares worth $505K. The largest sale was CareDx, an estimated $18.3M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 39% a quarter earlier, followed by Technology and Industrials.

  • Gagnon Securities's largest Q3 2024 buy was Intel: 21,514 shares worth $505K.
  • Gagnon Securities added most to Treace Medical Concepts in Q3 2024, an estimated $8.26M increase.
  • Gagnon Securities's biggest Q3 2024 reduction was CareDx, cutting an estimated $18.3M.
  • Gagnon Securities fully exited Shell in Q3 2024, selling an estimated $332K.
  • Gagnon Securities's ten largest holdings make up 49% of its $504M portfolio in Q3 2024.
  • Gagnon Securities opened 11 new positions and closed 6 in Q3 2024.
  • Gagnon Securities's portfolio value rose 14% quarter-over-quarter to $504M.

Based on Gagnon Securities's 13F filing for Q3 2024, filed 12 Nov 2024.